Jovenal, Baby Girl .
HRN: 22-65-37 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/27/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/27/2023
04/03/2023
IV
150mg
BID
Empiric
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes